Nalaganje...
Dual Antiplatelet Therapy Beyond 90 Days in Symptomatic Intracranial Stenosis in the SAMMPRIS Trial
BACKGROUND: The safety and efficacy of dual antiplatelet use for symptomatic intracranial atherosclerosis beyond 90 days is unknown. Data from SAMMPRIS was used to determine if dual antiplatelet therapy (DAPT) beyond 90 days impacted the risk of ischemic stroke and hemorrhage. METHODS: This post hoc...
Shranjeno v:
| izdano v: | J Stroke Cerebrovasc Dis |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7686095/ https://ncbi.nlm.nih.gov/pubmed/32992190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2020.105254 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|